The UConn Technology Incubation Program announced Wednesday that three new companies have joined its roster of 22 startups doing medical and technology research.
Lipid Genomics, founded by UConn Health Center faculty member Annabelle Rodriguez-Oquendo, moved into the UConn incubator to conduct clinical trials on a cholesterol drug. The company’s market value is $4.2 billion.
Diameter Health, led by CEO Eric Rosow and President John D’Amore, is developing technologies to help doctors and other health providers efficiently use data and succeed in an era of health reform.
Shoreline Biome, founded by Mark Driscoll and Thomas Jarvie, plans to develop treatments targeting the trillions of microbes that live on and within the body. The founders used to work at 454 Life Sciences in Branford, whose closure was announced in 2013.
The UConn incubator plans on adding another 28,000 square feet in December at its Farmington facility near the UConn Health Center to accommodate more startups coming out of UCHC and Jackson Laboratory.
